Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Cash from Operations (2020 - 2025)

Roivant Sciences (ROIV) has disclosed Cash from Operations for 6 consecutive years, with 196484000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 70.54% year-over-year to 196484000.0, compared with a TTM value of 1253417000.0 through Dec 2025, up 29.71%, and an annual FY2025 reading of 839451000.0, down 9.69% over the prior year.
  • Cash from Operations was 196484000.0 for Q4 2025 at Roivant Sciences, down from 185664000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 120596000.0 in Q3 2021 and bottomed at 666886000.0 in Q4 2024.
  • Average Cash from Operations over 5 years is 314284333.33, with a median of 204383000.0 recorded in 2025.
  • The sharpest move saw Cash from Operations plummeted 187.71% in 2021, then skyrocketed 70.54% in 2025.
  • Year by year, Cash from Operations stood at 530260000.0 in 2021, then dropped by 25.28% to 664305000.0 in 2022, then rose by 1.13% to 656811000.0 in 2023, then dropped by 1.53% to 666886000.0 in 2024, then surged by 70.54% to 196484000.0 in 2025.
  • Business Quant data shows Cash from Operations for ROIV at 196484000.0 in Q4 2025, 185664000.0 in Q3 2025, and 204383000.0 in Q2 2025.